Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy

NCT04302454 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Radiotherapy
DRUG: Leuprorelin

Sponsor

University Medical Center Groningen

Collaborators

[object Object]